A Novel Method Using Dual-Energy Computed Tomography for Detecting Amiodarone-Induced Lung Injury: A Cohort Pilot Study [0.03%]
一种使用双重能量CT检测胺碘酮所致肺毒性的新型方法：队列 pilot 研究
Naama R Bogot,Ariel Rokach,Irith Hadas-Halperen et al.
Naama R Bogot et al.
Background and objective: Amiodarone is an antiarrhythmic agent containing iodine. Amiodarone-induced lung disease (AILD) is a serious adverse effect that is difficult to diagnose. We aimed to evaluate the added value of ...
Can Patient Education Lead the Way? Head-To-Head Comparison of EXACT and CERT for Early Recognition of Acute COPD Exacerbations [0.03%]
患者教育能否起到引领作用？EXACT和CERT在早期识别急性COPD加重方面的头对头比较
Rainer Gloeckl,Paul W Jones,Daniela Kroll et al.
Rainer Gloeckl et al.
Background and objective: Acute exacerbations of COPD (AECOPD) worsen outcomes, yet they are often underreported. The 14-item EXACT diary has been validated for trial use-the five-item CERT checklist is patient-centered. ...
Mark Lavercombe
Mark Lavercombe
Towards Better Recognition of COPD Exacerbations With Patient-Centred Reporting Tools [0.03%]
基于患者报告工具的慢性阻塞性肺病急性加重期识别研究
Hao Wang,Ross Vlahos,Steven Bozinovski
Hao Wang
A New, Rapid Way to Test for Autoimmune Pulmonary Alveolar Proteinosis [0.03%]
一种检测自身免疫性肺泡蛋白沉积病的新型快速方法
Elinor Lee
Elinor Lee
Illuminating the Airway-Lessons From a Series of Tracheobronchial Amyloidosis [0.03%]
气道疾病的光明天地-一组支气管浆细胞瘤患者的启示
Naofumi Shinagawa
Naofumi Shinagawa
Naoya Tanabe
Naoya Tanabe
Validation and Further Analysis of the COPD Exacerbation Recognition Tool (CERT) [0.03%]
慢性阻塞性肺病急性加重预警工具（CERT）的验证及进一步分析
Xiangju Xing,Xiang Liu,Paul W Jones et al.
Xiangju Xing et al.
Background and objective: The COPD Exacerbation Recognition Tool (CERT) contains five symptoms that may change at the onset of an exacerbation. It was designed to help patients with COPD recognise the onset of an exacerba...
From Tradition to Transformation: A New Era of Primary Spontaneous Pneumothorax Management [0.03%]
从传统到变革：原发性自发性气胸治疗的新时代
Nai-Chien Huan,Diana Egerton-Warburton,Y C Gary Lee
Nai-Chien Huan